Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease

Burak KATİPOĞLU, (Ankara Eğitim ve Araştırma Hastanesi, Acil Tıp Kliniği, Ankara, Türkiye)
Ali AYGÜN, (Ordu Üniversitesi Tıp Fakültesi, Acil Tıp Anabilim Dalı)
Selim DEMİR, (Karadeniz Technical University, Faculty of Health Sciences, Department of Nutrition and Dietetics, 61080, Trabzon)
Özgür TATLI, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Trabzon, Türkiye)
Ahmet MENTEŞE, (Karadeniz Teknik Üniversitesi, Sağlık Bilimleri MYO, Tıbbı Laboratuvar Teknikleri A.D)
Ümit MENTEŞE, (Ahi Evren Göğüs ve Kalp Damar Cerrahisi Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Kliniği, Trabzon, Türkiye)
Gökalp ALTUN, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı, Trabzon, Türkiye)
Asım ÖREM, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Biyokimya Anabilim Dalı, Trabzon, Türkiye)
Abdülkadir GÜNDÜZ, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Trabzon, Türkiye)
Semih KORKUT (Ufuk Üniversitesi, Tıp Fakültesi, Dr. Ridvan Ege Eğitim ve Araştırma Hastanesi, Acil Tıp Anabilim Dalı, Ankara, Türkiye)
Eurasian Journal of Emergency Medicine
0 0
Yıl: 2018 Cilt: 17 Sayı: 4 Sayfa Aralığı: 187 - 192 Metin Dili: İngilizce DOI: 10.5152/eajem.2017.06977 İndeks Tarihi: 24-09-2019

Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease

Öz:
Aim: Atherosclerosis is a chronic inflammatory process associated with peripheral artery disease (PAD). The aim of this study was to investigate the role of pentraxin (PTX) as an inflammatory marker in the pathogenesis of PAD.Materials and Methods: This cross-sectional clinical study was performed at the tertiary university hospital emergency department and cardiovascular sur-gery departments in Turkey. The purpose was to determine the value of PTX3 in the diagnosis of PAD. This study was performed on 43 symptomatic patients aged >18 years and diagnosed with PAD.Results: Median PTX3 value was 1.027 (25–75th percentile: 0.395–2.902) in the control group and 0.585 (25–75th percentiles: 0.406–5.467) in the PAD group (p=0.913). A comparison of PTX3 with ankle brachial index (ABI) values revealed a weak and non-significant correlation (rho: 0.016, p=0.886). Analysis of PTX3 values with other parameters (age, systolic and diastolic blood pressure, heart rate, respiratory rate, temperature, and SpO2) revealed no significant correlation with any of the other parameters.Conclusion: Our findings indicate that PTX3 levels cannot be used as a marker in patients with the chronic process of PAD.
Anahtar Kelime:

Konular: Acil Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Cecilia A. Gutierrez. Peripheral Arterial Disease. In: Paulman PM, Paulman AA, Harrison Taylor JD, editors.Taylor’s Manual of Family Medicine. Philadelphia: Lippincott Williams &Wilkins; 2008. p.339-43.
  • Van der Wal AC, Becker AE, Das PK. Medial thinning and atherosclerosis--evidence for involvement of a local inflammatory effect. Atherosclerosis. 1993; 103: 55-64. [CrossRef]
  • Fazzini F, Peri G, Doni A, Dell’Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2001; 44: 2841-50. [CrossRef]
  • Carbayo JA, Divisón JA, Escribano J, López-Abril J, de Coca EL, Artigao LM, et al. Using ankle-brachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis. 2007; 17: 41-9. [CrossRef]
  • Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol. 2006; 98: 1226-30. [CrossRef]
  • Karabay O, Karacelik M, Yilik L, Tekin N, Iriz AB, Kumdereli S, et al. Ischemic peripheral arterial disease: A screening survey. Turk J Thoracic Cardiovasc Surg. 2012; 20: 450-7. [CrossRef]
  • Ambrosetti M. Timely diagnosis of lower extremity peripheral arterial disease: one of the many expected actions by the cardiologist. Int J Cardiol. 2014; 175: 217. [CrossRef]
  • Akman L, Erbas O, Terek MC, Aktug H, Taskiran D, Askar N. The long pentraxin-3 is a useful marker for diagnosis of ovarian torsion: An experimental rat model. J Obstet Gynaecol. 2016; 36: 399-402. [CrossRef]
  • Tatlı O, Keha Kurt N, Karaca Y, Sahin A, Aygun A, Sahin E, et al. The diagnostic value of serum pentraxin 3 levels in pulmonarycontusion. Am J Emerg Med. 2017; 35: 425-8. [CrossRef]
  • Tomandlova M, Jarkovsky J, Tomandl J, Kubkova L, Kala P, Littnerova S, et al. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress. Dis Markers. 2015; 2015: 159051. [CrossRef]
  • Zhou Y, Ni Z, Zhang J, Zhang W, Wu Q, Shen G, et al. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein. Vasc Med. 2013; 18: 85-91. [CrossRef]
  • Morishita T, Uzui H, Nakano A, Mitsuke Y, Geshi T, Ueda T, et al. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb. 2012; 19: 149-58. [CrossRef]
  • Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2007; 27: 161-7. [CrossRef]
  • Rashtchizadeh N, Sede SA, Ghaffari MA, Mohammadzadeh G, Majidi S. Associations of pentraxin 3 with presence and severity of coronary artery disease in type 2 diabetes patients. Turk J Biochemistry. 2015; 40: 37-43. [CrossRef]
  • Ishihara T, Haraguchi G, Kamiishi T, Tezuka D, Inagaki H, Isobe M. Sensitive assessment of activity of Takayasu’s arteritis by pentraxin3, a new biomarker. J Am Coll Cardiol. 2011; 57: 1712-3. [CrossRef]
  • Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality. JAMA. 2008; 300: 197-208. [CrossRef] Mautner GC, Mautner SL, Roberts WC. Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol. 1992; 70: 1147-51. [CrossRef]
APA katipoglu b, Aygun A, Demir S, Tatli O, Mentese A, MENTEŞE Ü, ALTUN G, Orem A, GÜNDÜZ A, KORKUT S (2018). Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. , 187 - 192. 10.5152/eajem.2017.06977
Chicago katipoglu burak,Aygun Ali,Demir Selim,Tatli Ozgur,Mentese Ahmet,MENTEŞE Ümit,ALTUN Gökalp,Orem Asım,GÜNDÜZ Abdülkadir,KORKUT SEMİH Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. (2018): 187 - 192. 10.5152/eajem.2017.06977
MLA katipoglu burak,Aygun Ali,Demir Selim,Tatli Ozgur,Mentese Ahmet,MENTEŞE Ümit,ALTUN Gökalp,Orem Asım,GÜNDÜZ Abdülkadir,KORKUT SEMİH Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. , 2018, ss.187 - 192. 10.5152/eajem.2017.06977
AMA katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. . 2018; 187 - 192. 10.5152/eajem.2017.06977
Vancouver katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. . 2018; 187 - 192. 10.5152/eajem.2017.06977
IEEE katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S "Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease." , ss.187 - 192, 2018. 10.5152/eajem.2017.06977
ISNAD katipoglu, burak vd. "Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease". (2018), 187-192. https://doi.org/10.5152/eajem.2017.06977
APA katipoglu b, Aygun A, Demir S, Tatli O, Mentese A, MENTEŞE Ü, ALTUN G, Orem A, GÜNDÜZ A, KORKUT S (2018). Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. Eurasian Journal of Emergency Medicine, 17(4), 187 - 192. 10.5152/eajem.2017.06977
Chicago katipoglu burak,Aygun Ali,Demir Selim,Tatli Ozgur,Mentese Ahmet,MENTEŞE Ümit,ALTUN Gökalp,Orem Asım,GÜNDÜZ Abdülkadir,KORKUT SEMİH Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. Eurasian Journal of Emergency Medicine 17, no.4 (2018): 187 - 192. 10.5152/eajem.2017.06977
MLA katipoglu burak,Aygun Ali,Demir Selim,Tatli Ozgur,Mentese Ahmet,MENTEŞE Ümit,ALTUN Gökalp,Orem Asım,GÜNDÜZ Abdülkadir,KORKUT SEMİH Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. Eurasian Journal of Emergency Medicine, vol.17, no.4, 2018, ss.187 - 192. 10.5152/eajem.2017.06977
AMA katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. Eurasian Journal of Emergency Medicine. 2018; 17(4): 187 - 192. 10.5152/eajem.2017.06977
Vancouver katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease. Eurasian Journal of Emergency Medicine. 2018; 17(4): 187 - 192. 10.5152/eajem.2017.06977
IEEE katipoglu b,Aygun A,Demir S,Tatli O,Mentese A,MENTEŞE Ü,ALTUN G,Orem A,GÜNDÜZ A,KORKUT S "Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease." Eurasian Journal of Emergency Medicine, 17, ss.187 - 192, 2018. 10.5152/eajem.2017.06977
ISNAD katipoglu, burak vd. "Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease". Eurasian Journal of Emergency Medicine 17/4 (2018), 187-192. https://doi.org/10.5152/eajem.2017.06977
Sayfa Oluşturulma Tarihi
23-04-2024 8:50

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları